KISS1	O
methylation	O
and	O
expression	O
as	O
tumor	B-Cancer
stratification	O
biomarkers	O
and	O
clinical	O
outcome	O
prognosticators	O
for	O
bladder	B-Cancer
cancer	I-Cancer
patients	O
.	O

KISS1	O
is	O
a	O
metastasis	O
suppressor	O
gene	O
that	O
is	O
lost	O
in	O
several	O
malignancies	B-Cancer
,	O
including	O
bladder	B-Cancer
cancer	I-Cancer
.	O

We	O
tested	O
the	O
epigenetic	O
silencing	O
hypothesis	O
and	O
evaluated	O
the	O
biological	O
influence	O
of	O
KISS1	O
methylation	O
on	O
its	O
expression	O
and	O
clinical	O
relevance	O
in	O
bladder	B-Cancer
cancer	I-Cancer
.	O

KISS1	O
hypermethylation	O
was	O
frequent	O
in	O
bladder	B-Cell
cancer	I-Cell
cells	I-Cell
analyzed	O
by	O
methylation	O
-	O
specific	O
PCR	O
and	O
bisulfite	O
sequencing	O
and	O
was	O
associated	O
with	O
low	O
gene	O
expression	O
,	O
being	O
restored	O
in	O
vitro	O
by	O
demethylating	O
azacytidine	O
.	O

Hypermethylation	O
was	O
also	O
frequently	O
observed	O
in	O
a	O
large	O
series	O
of	O
bladder	B-Cancer
tumors	I-Cancer
(	O
83	O
.	O
1	O
%	O
,	O
n	O
=	O
804	O
)	O
.	O

KISS1	O
methylation	O
was	O
associated	O
with	O
increasing	O
stage	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
tumor	B-Cancer
grade	O
(	O
P	O
=	O
0	O
.	O
010	O
)	O
.	O

KISS1	O
methylation	O
was	O
associated	O
with	O
low	O
KISS1	O
transcript	O
expression	O
by	O
quantitative	O
RT	O
-	O
PCR	O
(	O
P	O
=	O
0	O
.	O
037	O
)	O
.	O

KISS1	O
transcript	O
expression	O
was	O
also	O
associated	O
with	O
histopathological	O
tumor	B-Cancer
stage	O
(	O
P	O
<	O
0	O
.	O
0005	O
)	O
.	O

Low	O
transcript	O
expression	O
alone	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
or	O
combined	O
with	O
methylation	O
(	O
P	O
=	O
0	O
.	O
019	O
)	O
was	O
associated	O
with	O
poor	O
disease	O
-	O
specific	O
survival	O
(	O
n	O
=	O
205	O
)	O
.	O

KISS1	O
transcript	O
expression	O
remained	O
an	O
independent	O
prognosticator	O
in	O
multivariate	O
analyses	O
(	O
P	O
=	O
0	O
.	O
017	O
)	O
.	O

KISS1	O
hypermethylation	O
was	O
identified	O
in	O
bladder	B-Cancer
cancer	I-Cancer
,	O
providing	O
a	O
potential	O
mechanistic	O
explanation	O
(	O
epigenetic	O
silencing	O
)	O
for	O
the	O
observed	O
loss	O
of	O
KISS1	O
in	O
uroepithelial	B-Cancer
malignancies	I-Cancer
.	O

Associations	O
of	O
KISS1	O
methylation	O
and	O
its	O
expression	O
with	O
histopathological	O
variables	O
and	O
poor	O
survival	O
suggest	O
the	O
utility	O
of	O
incorporating	O
KISS1	O
measurement	O
using	O
paraffin	O
-	O
embedded	O
material	O
for	O
tumor	B-Cancer
stratification	O
and	O
clinical	O
outcome	O
prognosis	O
of	O
patients	O
with	O
uroepithelial	B-Cancer
neoplasias	I-Cancer
.	O

